LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 213 filers reported holding LOXO ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $5,961,000 | +67.0% | 49,480 | +51.7% | 0.00% | +100.0% |
Q3 2018 | $3,570,000 | +32.4% | 32,621 | +22.2% | 0.00% | 0.0% |
Q2 2018 | $2,696,000 | +23.8% | 26,705 | -31.4% | 0.00% | 0.0% |
Q1 2018 | $2,177,000 | +57.0% | 38,938 | +1.1% | 0.00% | – |
Q4 2017 | $1,387,000 | -16.5% | 38,510 | +113.6% | 0.00% | -100.0% |
Q3 2017 | $1,661,000 | +28.7% | 18,028 | +12.0% | 0.00% | – |
Q2 2017 | $1,291,000 | +97.7% | 16,095 | +3.8% | 0.00% | – |
Q1 2017 | $653,000 | +75.1% | 15,503 | +33.3% | 0.00% | – |
Q4 2016 | $373,000 | +116.9% | 11,628 | +76.6% | 0.00% | – |
Q3 2016 | $172,000 | +57.8% | 6,584 | +39.8% | 0.00% | – |
Q2 2016 | $109,000 | -18.0% | 4,710 | -3.6% | 0.00% | – |
Q1 2016 | $133,000 | -0.7% | 4,884 | +3.0% | 0.00% | – |
Q4 2015 | $134,000 | +644.4% | 4,741 | +359.4% | 0.00% | – |
Q3 2015 | $18,000 | -28.0% | 1,032 | -25.8% | 0.00% | – |
Q2 2015 | $25,000 | -10.7% | 1,390 | -40.7% | 0.00% | – |
Q1 2015 | $28,000 | +1300.0% | 2,344 | +1295.2% | 0.00% | – |
Q4 2014 | $2,000 | – | 168 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |